Researcher
Dr. Danny R. Welch
Kansas Comprehensive Cancer Center
Biography & Research Background
Danny R. Welch, PhD, is affiliated with the University of Kansas Comprehensive Cancer Center (previously University of Alabama at Birmingham). Dr. Welch led the research team that originally discovered the KiSS-1 gene in 1996, identifying it as a metastasis suppressor in human malignant melanoma cells. He named the gene 'KiSS-1' in homage to the discovery location near the Hershey's Kisses chocolate factory, with 'SS' denoting 'suppressor sequence.' His foundational work established the entire kisspeptin field, which has since expanded from cancer biology into reproductive endocrinology, metabolic science, and neuroscience. Danny R. Welch is being referenced as one of the leading scientists involved in the research and development of Kisspeptin. In no way is this doctor/scientist endorsing or advocating the purchase, sale, or use of this product for any reason. There is no affiliation or relationship, implied or otherwise, between FNTN Health and this doctor.
External Profiles
Authored Research Profiles (1)
Dr. Danny R. Welch is referenced as a leading researcher in the following peptide research profiles on FNTN Health:
Disclaimer
Dr. Danny R. Welch is being referenced as one of the leading scientists involved in the research and development of the peptides listed above. In no way is this doctor/scientist endorsing or advocating the purchase, sale, or use of any product for any reason. There is no affiliation or relationship, implied or otherwise, between FNTN Health and this researcher. The purpose of citing the researcher is to acknowledge, recognize, and credit the exhaustive research and development efforts conducted by the scientists studying these peptides.